Key highlights Broad catalog
For medical professionals considering BPC-157 in clinical practice, current use must acknowledge the investigational nature of the peptide and proceed within appropriate ethical frameworks including informed consent, safety monitoring, and outcome documentation
10.1016/j.copbio.2012.08.005 34 McGuireS
AFTER TREATMENT After treatment you may have a tiny amount of redness at the injection site
HUBERMAN: And that's one of the major issues with BPC-157 that's not often discussed, which is that if you have a tumor, and tumors thrive on increased blood flow because they like to consume growth factors and increased blood flow means increased growth factors and other things that can not just sustain but actually grow the tumor, well then by taking BPC-157, you may be either maintaining or accelerating the growth of a tumor that would otherwise be removed or stay small
In a 2021 retrospective study, Lee and Padgett compared the effectiveness of knee injections using BPC- 157 alone to knee injections using a combination of BPC-157 and thymosin-beta-4 (TB4), which is another peptide shown to have anti-inflammatory properties